Overview

Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Open label, non-comparative, prospective study to evaluate cognitive functioning in remitted depression outpatients during long-term preventive treatment with Fluvoxamine (Fevarin®)
Phase:
Phase 4
Details
Lead Sponsor:
Moscow Research Institute of Psychiatry
Collaborator:
Abbott
Treatments:
Fluvoxamine